Global On-body Injectors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global On-body Injectors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global On-body Injectors market size was valued at USD 148.2 million in 2022 and is forecast to a readjusted size of USD 378.9 million by 2029 with a CAGR of 14.4% during review period.

On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.

The scope of this report is non-insulin On-body injectors.

In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.

The Global Info Research report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronic Injectors, Mechanical Injectors), Cardiovascular Diseases (Electronic Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.

Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronic Injectors, Mechanical Injectors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.

Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to On-body Injectors:

Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, Cardiovascular Diseases).

Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

On-body Injectors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Electronic Injectors
Mechanical Injectors

Market segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others

Major players covered
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2018 to 2023.

Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.

Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.